Datasets
We employed 13 immune checkpoint blockade (ICB) response cohorts derived from 11 published studies, encompassing a total of 1,214 patients (31.8% responders). Metastatic melanoma was the most frequently studied cancer type, while other…
We employed 13 immune checkpoint blockade (ICB) response cohorts derived from 11 published studies, encompassing a total of 1,214 patients (31.8% responders). Metastatic melanoma was the most frequently studied cancer type, while other…